{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:10:09Z","timestamp":1778829009075,"version":"3.51.4"},"reference-count":0,"publisher":"Cell Physiol Biochem Press GmbH and Co KG","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Physiol Biochem"],"abstract":"<jats:p>Background\/Aims: The management of multiple myeloma (MM), a formidable hematological malignancy, continues to pose substantial challenges in the medical realm. Schisandrin B (Sch B), a compound derived from Traditional Chinese Medicine, has demonstrated potent anti-tumorigenic properties, providing a promising avenue for therapeutic intervention in this disease. However, the impact of Sch B on MM in vivo remains unexplored. Methods: The impact of Sch B on tumor growth was evaluated through precise measurements of body weight, tumor volume and cell proliferation. The progression of the cell cycle and the induction of apoptosis were examined utilizing flow cytometry. ELISA was conducted to quantify the levels of interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF). Immunofluorescence assays was employed to check the concentration of reactive oxygen species (ROS). Finally, western blot technique was employed to determine the expression levels of IL-6, JAK2, phosphorylated JAK2 (p-JAK2), STAT3, and phosphorylated STAT3 (p-STAT3) in order to gain insights into their relative abundance and activation status. Results: Our findings demonstrated that Sch B exhibited a profound inhibitory effect on the proliferation of transplanted tumors, effectively arresting them at the S phase of the cell cycle and triggering cell apoptosis. Furthermore, it was observed that Sch B exerted a down-regulatory influence on the expression of IL-6, VEGF, p-JAK2, and p-STAT3, while concurrently upregulating the levels of ROS in mice afflicted with MM. Importantly, a synergistic effect was noted when Sch B was administered in combination with bortezomib. Conclusion: Sch B emerges as a promising agent for the treatment of MM, and its efficacy is significantly enhanced when coupled with bortezomib.<\/jats:p>","DOI":"10.33594\/000000870","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:28:38Z","timestamp":1778826518000},"page":"270-279","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the Influence of Schisandrin B on Mice with Multiple Myeloma"],"prefix":"10.33594","volume":"60","author":[{"given":"Anna","family":"Li","sequence":"first","affiliation":[{"name":"Department of Hematology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang 330006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongchao","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang 330006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang 330006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang 330006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang 330006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caishui","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang 330006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang 330006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jiangxi Provincial People\u2019s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang 330006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"19235","published-online":{"date-parts":[[2026,3,5]]},"container-title":["Cellular Physiology and Biochemistry"],"original-title":[],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:28:39Z","timestamp":1778826519000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellphysiolbiochem.com\/Articles\/000870\/index.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,5]]}},"URL":"https:\/\/doi.org\/10.33594\/000000870","relation":{},"ISSN":["1015-8987","1421-9778"],"issn-type":[{"value":"1015-8987","type":"print"},{"value":"1421-9778","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]}}}